Sarepta Therapeutics Inc (NASDAQ:SRPT)

21.94
Real-Time Quote
 +0.84 / +3.98%
Today’s Change
12.12
Today|||52-Week Range
55.61
+7.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$863.5M

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-3700
Investor Relations:
(857) 242-3714

Employees

Shareholders

Mutual fund holders36.79%
Other institutional29.35%
Individual stakeholders0.61%

Top Executives

Christopher Nishan GarabedianPresident, Chief Executive Officer & Director
Sandesh MahatmeSenior VP, Chief Financial & Accounting Officer
Patrick L. IversenSenior Vice President-Research & Innovation
Edward M. KayeChief Medical Officer & Senior Vice President
David Tyronne HowtonSecretary, Senior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.